Updated Jul 16, 2026
CAREY STEPHEN P. has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $6.06M.

Stephen P. Carey is the Senior Vice President and Chief Financial Officer of ANI Pharmaceuticals Inc, a company that develops and markets generic prescription pharmaceuticals. He has been involved in the financial operations of the company, as indicated by his roles and SEC filings.
| Role | SVP & CFO |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-07 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 3.3K | $86.00 | $285K |
| 2026-07-07 | ANIP | ANI PHARMACEUTICALS INC | M — Option exercise | 3.3K | $49.51 | $164K |
| 2026-06-30 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 2.9K | $84.12 | $240K |
| 2026-06-09 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 3.3K | $80.00 | $265K |
| 2026-06-09 | ANIP | ANI PHARMACEUTICALS INC | M — Option exercise | 3.3K | $49.51 | $164K |
| 2026-03-10 | ANIP | ANI PHARMACEUTICALS INC | F — Tax withholding / forfeiture | 5.2K | $74.04 | $381K |
| 2026-03-05 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 4.0K | $75.56 | $302K |
| 2026-03-05 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 3.3K | $75.42 | $250K |
| 2026-03-05 | ANIP | ANI PHARMACEUTICALS INC | M — Option exercise | 3.3K | $49.51 | $164K |
| 2026-03-02 | ANIP | ANI PHARMACEUTICALS INC | F — Tax withholding / forfeiture | 2.8K | $73.90 | $205K |
| 2026-03-02 | ANIP | ANI PHARMACEUTICALS INC | A — Grant or award | 22.2K | $77.15 | $1.72M |
| 2026-02-17 | ANIP | ANI PHARMACEUTICALS INC | F — Tax withholding / forfeiture | 2.4K | $77.36 | $189K |
| 2026-02-17 | ANIP | ANI PHARMACEUTICALS INC | F — Tax withholding / forfeiture | 2.8K | $76.70 | $217K |
| 2026-02-13 | ANIP | ANI PHARMACEUTICALS INC | F — Tax withholding / forfeiture | 5.5K | $76.25 | $420K |
| 2025-08-12 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 50.0K | $86.07 | $4.30M |
| 2025-08-12 | ANIP | ANI PHARMACEUTICALS INC | M — Option exercise | 50.0K | $46.49 | $2.32M |
| 2024-12-18 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 7.5K | $55.79 | $418K |
Stephen P. Carey is the Senior Vice President and Chief Financial Officer of ANI Pharmaceuticals Inc, a company that develops and markets generic prescription pharmaceuticals. He has been involved in the financial operations of the company, as indicated by his roles and SEC filings.…
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 7 open-market sales ($6.06M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live CAREY STEPHEN P. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.